The future of Global Pharma

The future of Global Pharma



The global drug market will grow to 5 to 7 percent in 2011, to $880 billion, as higher spending in nations like China, Brazil and India makes up for slow growth and patent losses in the United States, according to a forecast released Wednesday by IMS Health, an industry data company. Prescription drug sales in 17 countries are growing at a 15 to 17 percent clip, led by China. It alone is expected to have sales growing at a rate of 25 to 27 percent to $50 billion next year, IMS Health said. Next year, patents expire on the two top-selling drugs in the world: Lipitor, the cholesterol drug from Pfizer, which had $13.2 billion in sales last year, and Plavix, the blood thinner from Bristol-Myers Squibb and Sanofi-Aventis, which had $9.1 billion in sales. Mr. Aitken said the full effect of lower-priced generic competition would be felt in 2012.

http://blogs.veedacr.com/Lists/Posts/Post.aspx?ID=345